By: Madison Muller
Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the company said, helping dispel lingering concerns over its potential as it nears regulatory review.


Madison Muller is a Health Reporter at Bloomberg. She covers a wide range of topics within the healthcare sector, focusing on medicine and healthcare systems, wellness, pharmaceuticals, and consumer health. Madison's work has been featured in prominent publications including TIME, The Washington Post, and Fortune, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Madison Muller's articles primarily focus on healthcare and pharmaceuticals, often referencing data and government announcements. She highlights news related to drug trials, pharmaceutical companies, and specific drugs' effects.
To effectively reach out to Madison, consider providing insights from industry experts or professionals with direct experience in the healthcare or pharmaceutical sectors. Given her reliance on data and government announcements, pitches backed by credible sources or studies may be particularly effective in capturing her attention.
It seems that Madison does not have a specific geographic focus but instead covers global developments within the healthcare and pharmaceutical industries. Therefore, when reaching out to her about industry trends or breaking news within these sectors, an international perspective could be valuable for your pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .